NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-53.89%
Change (1 year)
Categories
EPS for NGM Biopharmaceuticals (NGM)
EPS in 2023 (TTM): -$2.08
According to NGM Biopharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.08. In 2022 the company made an earnings per share (EPS) of -$2.05 a decrease over its 2021 EPS that were of -$1.56.
EPS history for NGM Biopharmaceuticals from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.08 | 1.46% |
| 2022 | -$2.05 | 31.41% |
| 2021 | -$1.56 | 4.7% |
| 2020 | -$1.49 | 128.06% |
| 2019 | -$0.65 | 1082.19% |
| 2018 | -$0.05527 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -87.02% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -51.92% | 🇺🇸 USA |